Uncategorized

Biogen filing reveals Apellis deal details; Telix raises $600M

Biogen filing reveals Apellis deal details; Telix raises $600M

Published

17 hours ago

on

Inside Biogen’s $5.6B buyout: CEO Chris Viehbacher has carried on with diversifying Biogen’s business beyond its legacy of high-risk bets in neurology. After paying $7.3 billion for Reata in 2023, Biogen​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version